Bio-Techne (TECH) Enterprise Value (2009 - 2026)

Bio-Techne's Enterprise Value history runs 18 years deep, the most recent figure standing at -$209.8 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 49.16% year-over-year to -$209.8 million in Q1 2026; TTM through Mar 2026 was -$209.8 million, a 49.16% decrease from a year earlier, with the FY2025 full-year figure at -$162.2 million, down 6.1% from the prior year.
• Enterprise Value slipped to -$209.8 million in Q1 2026 per TECH's latest filing, from -$172.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$135.7 million in Q4 2023 and bottomed at -$247.8 million in Q2 2022.
• The 5-year median for Enterprise Value is -$172.9 million (2025), against an average of -$177.6 million.
• Across the five-year window, Enterprise Value surged 32.31% in 2023 and tumbled 49.16% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$196.8 million in 2022, then soared by 31.06% to -$135.7 million in 2023, then tumbled by 30.89% to -$177.5 million in 2024, then increased by 2.63% to -$172.9 million in 2025, then dropped by 21.37% to -$209.8 million in 2026.
• Per Business Quant, the three latest TECH Enterprise Value figures stand at -$209.8 million (Q1 2026), -$172.9 million (Q4 2025), and -$145.0 million (Q3 2025).